It’s my core belief that as PYC advances VP-001/02, but more specifically CNS-001 the advancement of PYC’s RNA therapeutic platforms in tackling neurodegenerative disease will ameliorate other diseases as well given we have all been weaved together in our mother’s womb perfectly by God at creation’s outset - It’s a blessing to go on a journey to see if we can partake in correcting instructions to restore the woven tapestry that has degraded over time.
A year on - our one lead drug VP-001 is looking as promising as where we were a year ago. And we have two further lead candidates cooking in the oven. We have the potential to truly be valued as a company that will hopefully help thousands of patients in 2025 through a simple injection - with the potential to help tens if not hundreds more patients in the following years to come.
PYC Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)